Within the National Tuberculosis Control Programme of Malawi, misunderstand
ings sometimes occur about the diagnosis and management of recurrent tuberc
ulosis (TB). Patients with smear-positive pulmonary tuberculosis (PTB) who
have had a previous, treated episode of smear-negative TB may be registered
as 'new cases' rather than relapse cases, and thus denied the benefits of
a retreatment regimen. Patients with a recurrent episode of smear-negative
PTB or extra-pulmonary TB (EPTB) may also be wrongly registered as 'new cas
es' rather than recurrent cases. International guidelines about the treatme
nt of recurrent smear-negative PTB and EPTB are not explicit, resulting in
confusion about how best to manage these cases. It is suggested that all su
ch cases be considered for re-treatment regimen because of concerns about a
cquired drug resistance. WHO and IUATLD guidelines on the diagnosis and man
agement of recurrent and relapse TB need to be improved, and operational re
search studies should be conducted to provide answers to some outstanding q
uestions.